Session translationnelle : Neuropsychopharmacologie
mardi 24 juin 2025
Sessions parallèles
Sessions parallèles
•
S12
•
14h00
>
15h30
•
Session translationnelle : Neuropsychopharmacologie
•
IFPS - Amphi 3
Sessions parallèles
Modérateurs : Guillaume HACHE (Marseille), Marine AUFFRET (Lyon)
Conférence invitée
14h00 Innovation thérapeutique : Dopamine intracérébrale en anaérobie pour le traitement des complications liées à la L-dopa de la maladie de Parkinson - Caroline MOREAU (Lille)
Communications orales
•
15
•
CO-013 - Neuroprotective effect of BIO101 in vincristine-induced peripheral neuropathy
>
C.
Claire
Demiot
•
62
•
CO-014 - Health complications related to cocaine and crack: update of the French addictovigilance network data
>
C.
Céline
Eiden
•
90
•
CO-015 - Involvement of the BTK-NLRP3 signaling pathway in blood-brain barrier disruption and cognitive impairment induced during chronic kidney disease in rats
>
A.
Amandine
Bruyat
•
162
•
CO-016 - Prevention of opioid misuse and overdose and naloxone diffusion: overview of practices, needs and perspectives among community pharmacists
>
E.
Elisabeth
Frauger
•
230
•
CO-017 - Adverse drug reactions leading psychiatric inpatients transfer to a general hospital: the IATROPSY study
>
M.
Maxime
Demourgues
•
240
•
CO-018 - Evaluation of Clozapine-Norclozapine Joint Population Pharmacokinetic Models Using an Identifiability-Based Approach
>
S.
Stanislas
Maisonneuve
|